Chlorprothixen-neuraxpharm

Medicinal product

(Invented) name

Chlorprothixen-neuraxpharm

Active substance (s)

Chlorprotikseno hidrochloridas

Strength

50 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

N05AF03, Chlorprothixene

Marketing authorisation holder

UAB Niromed, Lietuva

Date of authorisation

2025-02-05

Date of renewal

Documents

2362_Chlorprothixen-neuraxpharm 50mg_pl_deng_tab_PL_2025-02-05.docx

2362_Chlorprothixen-neuraxpharm 50mg_pl_deng_tab_PZ_2025-02-05.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Tabletėje yra:	1 vnt.
Chlorprotikseno hidrochloridas	50 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
116532	102631	1102631	lizdinė plokštelė	N20		Receptinis	LT/L/25/2362/001	Netiekiama	-	-	No	-	-	Download
116533	102632	1102632	lizdinė plokštelė	N50		Receptinis	LT/L/25/2362/002	Netiekiama	-	-	No	-	-
116534	102633	1102633	lizdinė plokštelė	N100		Receptinis	LT/L/25/2362/003	Netiekiama	-	2025-05-07	No	-	-

Stadijos

Data	Stadija
2025-02-05	Registruotas